Ignite Creation Date:
2025-12-25 @ 4:54 AM
Ignite Modification Date:
2026-05-28 @ 10:45 AM
Study NCT ID:
NCT05133518
Status:
COMPLETED
Last Update Posted:
2022-12-19
First Post:
2021-11-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of MELT-300 (Midazolam and Ketamine Sublingual Tablets) for Sedation and Intraoperative Ocular Analgesia in Participants Undergoing Cataract Extraction With Lens Replacement (CELR)
Sponsor:
Melt Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MELT-2-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |